Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Meadows

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1S F Betz, A Schnuchel, H Wang, et al.
Nature|November 5, 1999
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAPC Sun, M Cai, A H Gunasekera, et al.
Biochemistry|January 26, 1993
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMRR P Meadows, D G Nettesheim, R X Xu, et al.
Biochemistry|April 26, 1994
Solution structure of the amino-terminal fragment of urokinase-type plasminogen activatorA P Hansen, A M Petros, R P Meadows, et al.
Nature|December 7, 1995
Structure and ligand recognition of the phosphotyrosine binding domain of ShcM M Zhou, K S Ravichandran, E F Olejniczak, et al.
Protein Science : a Publication of the Protein Society|February 24, 2001
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studiesA M Petros, D G Nettesheim, Y Wang, et al.
Cell|October 28, 1998
NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor TrioX Liu, H Wang, M Eberstadt, et al.
Science (New York, N.Y.)|February 14, 1997
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosisM Sattler, H Liang, D Nettesheim, et al.
Nature|May 23, 1996
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell deathS W Muchmore, M Sattler, H Liang, et al.
Journal of Medicinal Chemistry|December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailabilityPhilip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1S F Betz, A Schnuchel, H Wang, et al.
Nature|November 5, 1999
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAPC Sun, M Cai, A H Gunasekera, et al.
Biochemistry|January 26, 1993
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMRR P Meadows, D G Nettesheim, R X Xu, et al.
Biochemistry|April 26, 1994
Solution structure of the amino-terminal fragment of urokinase-type plasminogen activatorA P Hansen, A M Petros, R P Meadows, et al.
Nature|December 7, 1995
Structure and ligand recognition of the phosphotyrosine binding domain of ShcM M Zhou, K S Ravichandran, E F Olejniczak, et al.
Protein Science : a Publication of the Protein Society|February 24, 2001
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studiesA M Petros, D G Nettesheim, Y Wang, et al.
Cell|October 28, 1998
NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor TrioX Liu, H Wang, M Eberstadt, et al.
Science (New York, N.Y.)|February 14, 1997
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosisM Sattler, H Liang, D Nettesheim, et al.
Nature|May 23, 1996
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell deathS W Muchmore, M Sattler, H Liang, et al.
Journal of Medicinal Chemistry|December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailabilityPhilip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.
Pageof 10